3-94049499-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001174150.2(ARL13B):c.1118C>T(p.Thr373Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000385 in 1,608,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001174150.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARL13B | NM_001174150.2 | c.1118C>T | p.Thr373Met | missense_variant | 8/10 | ENST00000394222.8 | NP_001167621.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARL13B | ENST00000394222.8 | c.1118C>T | p.Thr373Met | missense_variant | 8/10 | 1 | NM_001174150.2 | ENSP00000377769 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000661 AC: 1AN: 151200Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000519 AC: 13AN: 250542Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135436
GnomAD4 exome AF: 0.0000418 AC: 61AN: 1457672Hom.: 0 Cov.: 30 AF XY: 0.0000414 AC XY: 30AN XY: 725132
GnomAD4 genome AF: 0.00000661 AC: 1AN: 151200Hom.: 0 Cov.: 31 AF XY: 0.0000136 AC XY: 1AN XY: 73756
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 26, 2021 | The c.1118C>T (p.T373M) alteration is located in exon 8 (coding exon 8) of the ARL13B gene. This alteration results from a C to T substitution at nucleotide position 1118, causing the threonine (T) at amino acid position 373 to be replaced by a methionine (M). The p.T373M alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Joubert syndrome 8 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 15, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 1061421). This variant has not been reported in the literature in individuals affected with ARL13B-related conditions. This variant is present in population databases (rs369850890, gnomAD 0.02%). This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 373 of the ARL13B protein (p.Thr373Met). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at